SAMRAT PHARMACHEM
|
SAMRAT PHARMACHEM Last 5 Year Balance Sheet History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| Share Capital | ₹3.09 Cr | ₹3.09 Cr | ₹3.09 Cr | ₹3.09 Cr | ₹3.09 Cr |
| Equity - Authorised | ₹5.00 Cr | ₹5.00 Cr | ₹5.00 Cr | ₹5.00 Cr | ₹5.00 Cr |
| Equity - Issued | ₹3.09 Cr | ₹3.09 Cr | ₹3.09 Cr | ₹3.09 Cr | ₹3.09 Cr |
| Equity Paid Up | ₹3.09 Cr | ₹3.09 Cr | ₹3.09 Cr | ₹3.09 Cr | ₹3.09 Cr |
| Equity Shares Forfeited | - | - | - | - | - |
| Adjustments to Equity | - | - | - | - | - |
| Preference Capital Paid Up | - | - | - | - | - |
| Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
| Share Warrants & Outstandings | - | - | - | - | - |
| Total Reserves | ₹69 Cr | ₹62 Cr | ₹60 Cr | ₹44 Cr | ₹27 Cr |
| Securities Premium | - | - | - | - | - |
| Capital Reserves | - | - | - | - | - |
| Profit & Loss Account Balance | ₹69 Cr | ₹62 Cr | ₹60 Cr | ₹44 Cr | ₹27 Cr |
| General Reserves | - | - | - | - | - |
| Other Reserves | - | - | - | - | - |
| Reserve excluding Revaluation Reserve | ₹69 Cr | ₹62 Cr | ₹60 Cr | ₹44 Cr | ₹27 Cr |
| Revaluation reserve | - | - | - | - | - |
| Shareholder's Funds | ₹72 Cr | ₹65 Cr | ₹63 Cr | ₹47 Cr | ₹30 Cr |
| Minority Interest | - | - | - | - | - |
| Long-Term Borrowings | - | - | - | - | - |
| Secured Loans | - | - | - | - | - |
| Non Convertible Debentures | - | - | - | - | - |
| Converible Debentures & Bonds | - | - | - | - | - |
| Packing Credit - Bank | - | - | - | - | - |
| Inter Corporate & Security Deposit | - | - | - | - | - |
| Term Loans - Banks | - | - | - | - | - |
| Term Loans - Institutions | - | - | - | - | - |
| Other Secured | - | - | - | - | - |
| Unsecured Loans | - | - | - | - | - |
| Fixed Deposits - Public | - | - | - | - | - |
| Loans and advances from subsidiaries | - | - | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
| Foreign Currency Convertible Notes | - | - | - | - | - |
| Long Term Loan in Foreign Currency | - | - | - | - | - |
| Loans - Banks | - | - | - | - | - |
| Loans - Govt. | - | - | - | - | - |
| Loans - Others | - | - | - | - | - |
| Other Unsecured Loan | - | - | - | - | - |
| Deferred Tax Assets / Liabilities | ₹0.11 Cr | ₹0.34 Cr | ₹0.25 Cr | ₹0.46 Cr | ₹0.43 Cr |
| Deferred Tax Assets | ₹0.72 Cr | ₹0.44 Cr | ₹0.43 Cr | ₹0.14 Cr | ₹0.10 Cr |
| Deferred Tax Liability | ₹0.83 Cr | ₹0.78 Cr | ₹0.68 Cr | ₹0.60 Cr | ₹0.53 Cr |
| Other Long Term Liabilities | - | - | - | - | - |
| Long Term Trade Payables | - | - | - | - | - |
| Long Term Provisions | - | - | - | - | - |
| Total Non-Current Liabilities | ₹0.11 Cr | ₹0.34 Cr | ₹0.25 Cr | ₹0.46 Cr | ₹0.43 Cr |
| Current Liabilities | - | - | - | - | - |
| Trade Payables | ₹39 Cr | ₹48 Cr | ₹32 Cr | ₹23 Cr | ₹18 Cr |
| Sundry Creditors | ₹39 Cr | ₹48 Cr | ₹32 Cr | ₹23 Cr | ₹18 Cr |
| Acceptances | - | - | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - | - | - |
| Other Current Liabilities | ₹0.14 Cr | ₹0.28 Cr | ₹0.52 Cr | ₹0.89 Cr | ₹0.17 Cr |
| Bank Overdraft / Short term credit | - | - | - | - | - |
| Advances received from customers | ₹0.00 Cr | ₹0.10 Cr | ₹0.44 Cr | - | - |
| Interest Accrued But Not Due | - | - | - | - | - |
| Share Application Money | - | - | - | - | - |
| Current maturity of Debentures & Bonds | - | - | - | - | - |
| Current maturity - Others | - | - | - | - | - |
| Other Liabilities | ₹0.14 Cr | ₹0.18 Cr | ₹0.08 Cr | ₹0.89 Cr | ₹0.17 Cr |
| Short Term Borrowings | ₹9.92 Cr | ₹8.46 Cr | ₹19 Cr | ₹7.52 Cr | ₹8.79 Cr |
| Secured ST Loans repayable on Demands | ₹9.92 Cr | ₹8.46 Cr | ₹19 Cr | ₹7.52 Cr | ₹8.79 Cr |
| Working Capital Loans- Sec | ₹9.92 Cr | ₹8.46 Cr | ₹19 Cr | ₹7.52 Cr | ₹8.79 Cr |
| Buyers Credits - Unsec | - | - | - | - | - |
| Commercial Borrowings- Unsec | - | - | - | - | - |
| Other Unsecured Loans | ₹-9.92 Cr | ₹-8.46 Cr | ₹-19 Cr | ₹-7.52 Cr | ₹-8.79 Cr |
| Short Term Provisions | ₹0.97 Cr | - | ₹2.14 Cr | ₹5.53 Cr | ₹0.70 Cr |
| Proposed Equity Dividend | - | - | - | - | - |
| Provision for Corporate Dividend Tax | - | - | - | - | - |
| Provision for Tax | ₹0.94 Cr | - | ₹2.14 Cr | ₹5.53 Cr | ₹0.68 Cr |
| Provision for post retirement benefits | - | - | - | - | ₹0.01 Cr |
| Preference Dividend | - | - | - | - | - |
| Other Provisions | ₹0.03 Cr | - | - | - | ₹0.02 Cr |
| Total Current Liabilities | ₹50 Cr | ₹56 Cr | ₹53 Cr | ₹37 Cr | ₹27 Cr |
| Total Liabilities | ₹121 Cr | ₹122 Cr | ₹117 Cr | ₹85 Cr | ₹57 Cr |
| ASSETS | |||||
| Gross Block | ₹17 Cr | ₹17 Cr | ₹16 Cr | ₹15 Cr | ₹14 Cr |
| Less: Accumulated Depreciation | ₹6.37 Cr | ₹5.89 Cr | ₹5.55 Cr | ₹4.91 Cr | ₹4.60 Cr |
| Less: Impairment of Assets | - | - | - | - | - |
| Net Block | ₹10 Cr | ₹11 Cr | ₹11 Cr | ₹9.99 Cr | ₹9.40 Cr |
| Lease Adjustment A/c | - | - | - | - | - |
| Capital Work in Progress | - | - | - | - | - |
| Non Current Investments | ₹3.44 Cr | ₹2.92 Cr | ₹1.86 Cr | - | - |
| Long Term Investment | ₹3.44 Cr | ₹2.92 Cr | ₹1.86 Cr | - | - |
| Quoted | ₹3.44 Cr | ₹2.92 Cr | ₹1.86 Cr | - | - |
| Unquoted | - | - | - | - | - |
| Long Term Loans & Advances | ₹0.75 Cr | ₹1.47 Cr | ₹0.91 Cr | ₹0.80 Cr | ₹0.65 Cr |
| Other Non Current Assets | ₹3.46 Cr | ₹4.06 Cr | ₹4.06 Cr | ₹2.56 Cr | ₹0.02 Cr |
| Total Non-Current Assets | ₹18 Cr | ₹19 Cr | ₹18 Cr | ₹13 Cr | ₹10 Cr |
| Current Assets Loans & Advances | - | - | - | - | - |
| Currents Investments | ₹0.36 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.00 Cr |
| Quoted | ₹0.36 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.00 Cr |
| Unquoted | - | - | - | - | - |
| Inventories | ₹38 Cr | ₹21 Cr | ₹33 Cr | ₹12 Cr | ₹11 Cr |
| Raw Materials | ₹21 Cr | ₹6.25 Cr | ₹13 Cr | ₹3.28 Cr | ₹2.57 Cr |
| Work-in Progress | ₹0.95 Cr | ₹0.43 Cr | ₹0.87 Cr | ₹0.17 Cr | ₹0.08 Cr |
| Finished Goods | ₹16 Cr | ₹14 Cr | ₹18 Cr | ₹8.90 Cr | ₹8.65 Cr |
| Packing Materials | ₹0.05 Cr | ₹0.07 Cr | ₹0.10 Cr | ₹0.08 Cr | ₹0.10 Cr |
| Stores  and Spare | - | - | - | - | - |
| Other Inventory | - | - | - | - | - |
| Sundry Debtors | ₹57 Cr | ₹69 Cr | ₹52 Cr | ₹44 Cr | ₹33 Cr |
| Debtors more than Six months | ₹0.30 Cr | ₹1.42 Cr | ₹0.19 Cr | ₹0.10 Cr | ₹0.02 Cr |
| Debtors Others | ₹56 Cr | ₹68 Cr | ₹52 Cr | ₹44 Cr | ₹33 Cr |
| Cash and Bank | ₹0.17 Cr | ₹9.73 Cr | ₹12 Cr | ₹15 Cr | ₹2.51 Cr |
| Cash in hand | ₹0.05 Cr | ₹0.05 Cr | ₹0.04 Cr | ₹0.04 Cr | ₹0.04 Cr |
| Balances at Bank | ₹0.12 Cr | ₹9.68 Cr | ₹12 Cr | ₹15 Cr | ₹2.47 Cr |
| Other cash and bank balances | - | - | - | - | - |
| Other Current Assets | ₹0.19 Cr | ₹0.07 Cr | ₹0.06 Cr | ₹0.07 Cr | ₹0.38 Cr |
| Interest accrued on Investments | ₹0.02 Cr | ₹0.02 Cr | ₹0.02 Cr | ₹0.03 Cr | ₹0.02 Cr |
| Interest accrued on Debentures | - | - | - | - | - |
| Deposits with Government | - | - | - | - | - |
| Interest accrued and or due on loans | - | - | - | - | - |
| Prepaid Expenses | ₹0.17 Cr | ₹0.05 Cr | ₹0.04 Cr | ₹0.02 Cr | ₹0.02 Cr |
| Other current_assets | - | - | ₹0.01 Cr | ₹0.02 Cr | ₹0.33 Cr |
| Short Term Loans and Advances | ₹8.11 Cr | ₹2.80 Cr | ₹2.88 Cr | ₹0.49 Cr | ₹0.04 Cr |
| Advances recoverable in cash or in kind | ₹7.91 Cr | ₹2.45 Cr | ₹0.07 Cr | ₹0.07 Cr | ₹0.02 Cr |
| Advance income tax and TDS | - | - | - | - | - |
| Amounts due from directors | - | - | - | - | - |
| Due From Subsidiaries | - | - | - | - | - |
| Inter corporate deposits | - | - | - | - | - |
| Corporate Deposits | - | - | - | - | - |
| Other Loans & Advances | ₹0.20 Cr | ₹0.35 Cr | ₹2.81 Cr | ₹0.42 Cr | ₹0.02 Cr |
| Total Current Assets | ₹103 Cr | ₹103 Cr | ₹99 Cr | ₹71 Cr | ₹47 Cr |
| Net Current Assets (Including Current Investments) | ₹54 Cr | ₹46 Cr | ₹46 Cr | ₹34 Cr | ₹20 Cr |
| Miscellaneous Expenses not written off | - | - | - | - | - |
| Total Assets | ₹121 Cr | ₹122 Cr | ₹117 Cr | ₹85 Cr | ₹57 Cr |
| Contingent Liabilities | - | ₹0.07 Cr | ₹0.07 Cr | ₹0.07 Cr | ₹0.07 Cr |
| Total Debt | ₹9.92 Cr | ₹8.46 Cr | ₹19 Cr | ₹7.52 Cr | ₹8.79 Cr |
| Book Value | 232.39 | 210.37 | 204.37 | 151.54 | 95.92 |
| Adjusted Book Value | 232.39 | 210.37 | 204.37 | 151.54 | 95.92 |
Compare Balance Sheet of peers of SAMRAT PHARMACHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAMRAT PHARMACHEM | ₹85.0 Cr | 0.6% | -7.7% | -41.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,566.0 Cr | 1.2% | 5.3% | 0.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,594.0 Cr | -0.7% | -2.1% | 12.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹125,826.0 Cr | -3.2% | 4.1% | 20.2% | Stock Analytics | |
| CIPLA | ₹123,504.0 Cr | -0.2% | -6.7% | 1.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,132.0 Cr | 0.2% | -2.7% | 2% | Stock Analytics | |
SAMRAT PHARMACHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAMRAT PHARMACHEM | 0.6% |
-7.7% |
-41.5% |
| SENSEX | 1.4% |
2% |
10.2% |
You may also like the below Video Courses